ArticleClinical immunology (Orlando, Fla.)2011

Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.

Anagha A Divekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.